Radioactive Materials Logistics Market By Material Type (Radiopharmaceuticals, Nuclear Fuel, Industrial Isotopes, Nuclear Waste); By Mode of Transport (Road, Air, Rail, Maritime); By End User (Nuclear Medicine Facilities, Power Plants, Research Labs, Defense Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Radioactive Materials Logistics Market Size (2024 – 2030): Statistical Snapshot

The Global Radioactive Materials Logistics Market is valued at USD 3.2 billion in 2024 and is projected to reach approximately USD 4.8 billion by 2030, growing at a CAGR of 5.9%, driven by expanding nuclear medicine procedures, rising isotope production for cancer diagnostics, modernization of nuclear power infrastructure, and increasing cross-border transport requirements for regulated radioactive materials.

 

Segment Breakdown

By Material Type

• Radiopharmaceuticals dominate with 38.4% share (USD 1.23 billion in 2024).

• Nuclear Fuel holds 29.1% share (USD 0.93 billion).

• Industrial Isotopes account for 19.6% share (USD 0.63 billion).

• Nuclear Waste represents 12.9% share (USD 0.41 billion).

 

By Mode of Transport

• Road Transport dominates with 44.8% share (USD 1.43 billion in 2024).

• Air Transport holds 27.3% share (USD 0.87 billion).

• Rail Transport accounts for 15.2% share (USD 0.49 billion).

• Maritime Transport represents 12.7% share (USD 0.41 billion).

 

By End User

• Nuclear Medicine Facilities dominate with 41.7% share (USD 1.33 billion in 2024).

• Power Plants hold 30.6% share (USD 0.98 billion).

• Research Labs account for 16.4% share (USD 0.52 billion).

• Defense Agencies represent 11.3% share (USD 0.37 billion).

 

By Region

• North America dominates with 35.8% share (USD 1.15 billion).

• Europe holds 29.7% share (USD 0.95 billion).

• Asia Pacific accounts for 24.6% share (USD 0.79 billion).

• Rest of the World represents 9.9% share (USD 0.31 billion).

 

Impact of Regulatory-Compliant Shielded Transport Systems on Radioactive Materials Logistics Market

Operational Benefit:

• Increasing deployment of certified Type A, Type B(U), and fissile-material transport containers has significantly reduced contamination exposure and shipment rejection rates across nuclear logistics networks. According to the International Atomic Energy Agency (IAEA) and U.S. Nuclear Regulatory Commission (NRC) transport compliance frameworks, engineered shielding and containment systems reduce radiological leakage risk by over 95% during normal transport conditions.

• The U.S. Department of Transportation (DOT) and NRC mandate rigorous packaging standards under 10 CFR Part 71 and 49 CFR radioactive material transport regulations, directly increasing demand for specialized logistics providers with certified handling infrastructure. This has contributed to an estimated operational compliance expenditure of over USD 420 million annually across North American nuclear logistics chains.

• Enhanced shielding technology improves cargo turnaround efficiency by reducing inspection delays and customs detention periods. Advanced container tracking and radiation-monitoring integration have lowered average international isotope shipment delays by nearly 18%, particularly for short half-life medical isotopes requiring time-sensitive delivery.

 

Efficiency Gain:

• Automated radiation-monitoring systems integrated into transport fleets have improved shipment traceability and incident-response efficiency by approximately 27% across regulated nuclear transport corridors.

• The U.S. Department of Energy (DOE) reported continued investment in nuclear fuel cycle transportation security infrastructure, supporting higher throughput capacity for radioactive cargo movement between enrichment facilities, reactors, and disposal locations.

• Adoption of digitally monitored shielded transport containers has reduced manual compliance inspection time by nearly 22%, improving fleet utilization rates and reducing idle transport costs for licensed carriers.

 

Strategic Implication:

• Rising compliance intensity associated with radiopharmaceutical distribution and spent fuel transportation is projected to generate an incremental market opportunity exceeding USD 1.1 billion by 2030 for specialized radioactive logistics operators, certified containment manufacturers, and secure transport service providers.

• Expansion of nuclear medicine programs supported by the U.S. Food and Drug Administration (FDA) and isotope production initiatives funded under the DOE Isotope Program are accelerating demand for high-frequency, temperature-controlled radioactive shipment networks.

• Regulatory tightening surrounding cross-border nuclear material handling under IAEA SSR-6 transport safety standards is expected to further consolidate the market toward operators with advanced compliance-certified logistics ecosystems.

 

Nuclear Medicine Isotope Distribution Networks Amplifying Radioactive Materials Logistics Market Growth

Market Share / Adoption:

• By 2026, approximately 48% of global radioactive material logistics demand linked to healthcare applications is expected to originate from nuclear medicine isotope transportation, representing nearly USD 1.7 billion in logistics-related revenue activity.

• According to the U.S. Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI), increasing cancer diagnostic imaging volumes are driving sustained growth in radiopharmaceutical transport requirements, particularly for Technetium-99m, Iodine-131, and PET imaging isotopes.

• The OECD Nuclear Energy Agency (NEA) has identified growing dependency on international isotope supply chains due to concentration of production reactors in limited geographies, increasing demand for rapid air-based radioactive logistics operations.

 

Operational / Financial Impact:

• Time-sensitive delivery requirements for short half-life isotopes have increased premium logistics pricing by nearly 31% compared with conventional hazardous material transport services.

• Specialized cold-chain radioactive logistics systems reduce isotope decay-related product losses by approximately 14%–19%, directly improving utilization economics for hospitals and nuclear imaging centers.

• Deployment of AI-assisted routing and radiation-monitoring systems has lowered failed medical isotope deliveries by approximately 16%, translating into estimated operational savings exceeding USD 85,000 annually per high-volume isotope distribution hub.

 

Policy / Industrial Driver:

• The U.S. Department of Energy’s Isotope Program continues expanding domestic isotope production and transport resilience initiatives to reduce dependency on foreign reactor supply chains.

• Nuclear medicine growth is additionally supported by healthcare infrastructure investments and radiopharmaceutical approval expansion under the FDA and coordinated nuclear safety transport standards governed by the IAEA and International Civil Aviation Organization (ICAO).

• Several countries across Europe and Asia Pacific are strengthening radioactive material transport licensing frameworks aligned with IAEA SSR-6 regulations, increasing long-term demand for certified logistics operators.

 

Strategic Outcome:

• Nuclear medicine isotope distribution is projected to contribute approximately 34% of total incremental market growth through 2030 by amplifying the need for rapid, shielded, compliance-intensive transport infrastructure with high reliability and low transit-loss rates.

 

Market Deep Dive

This market plays a critical but often overlooked role in the functioning of nuclear medicine, industrial radiography, nuclear power generation, and research applications. Transporting radioactive isotopes, nuclear fuels, and radiopharmaceuticals requires an exceptional degree of regulatory compliance, precision handling, and technical sophistication. Between 2024 and 2030, rising nuclear diagnostic demand, global energy security agendas, and the resurgence of next-generation nuclear reactors are converging to push radioactive materials logistics into the spotlight.

 

Demand isn’t coming from just one sector. In healthcare, radiopharmaceuticals used in PET and SPECT scans must be delivered under tight timeframes due to short half-lives — sometimes just hours. That creates a hyper-logistics requirement: temperature-controlled, shielded, and real-time tracked. In the industrial sector, gamma radiography and tracer studies continue to support construction, aerospace, and oil & gas pipeline diagnostics. Then there’s energy: enriched uranium, spent fuel rods, and waste materials are transported under multi-layered protocols, often across borders and oceans.

 

What’s changing now? For one, nuclear medicine is decentralizing . Instead of being concentrated in a few centers, cancer centers and cardiac imaging units in Tier 2 and Tier 3 cities are demanding timely radioisotope delivery. Also, new reactor designs and fuel cycles (like SMRs and thorium-based reactors) are shifting the mix of radioactive cargo and raising logistical complexity.

 

From a regulatory standpoint, standards are tightening. Agencies like the IAEA, NRC (U.S.), and Euratom have updated transport safety codes and cross-border shipment requirements. Logistics providers now need digital traceability, end-to-end shielding validation, and highly trained radiological safety personnel just to qualify.

 

Stakeholders here range from specialized third-party logistics (3PL) providers and container manufacturers to nuclear medicine suppliers, hospital networks, energy utilities, and government-run agencies. Even defense departments — often silent but steady customers — play a role in handling special nuclear material logistics.

 

2. Market Segmentation and Forecast Scope

The radioactive materials logistics market doesn’t follow the typical logistics playbook. It’s built around one core requirement: absolute control over time, shielding, and safety. That has led to a highly specialized segmentation structure, with demand defined less by volume and more by criticality.

Here’s how the market typically breaks down:

By Material Type

• Radiopharmaceuticals These are short-lived isotopes like Technetium-99m or Fluorine-18 used in nuclear imaging. Timing is everything here — shipments often happen daily via dedicated courier networks or chartered flights. This segment is the fastest-growing, driven by the global surge in PET-CT installations and oncology diagnostics. Radiopharmaceutical logistics alone is expected to contribute over 38.4% of market revenue in 2024.

• Nuclear Fuel (Uranium, MOX, Thorium ) Includes fresh fuel deliveries to nuclear plants as well as return of spent fuel for reprocessing or disposal. Regulatory oversight is highest in this segment.

• Industrial Radioisotopes Used in non-destructive testing, well-logging, and sterilization. These shipments often go to construction sites, offshore rigs, and industrial facilities, requiring robust container formats and route planning.

• Nuclear Waste Transport of low-, intermediate-, or high-level radioactive waste to storage or disposal sites. Often requires multilayer shielding and intermodal transport solutions.

 

By Mode of Transport

• Road Dominates short- to mid-range deliveries, especially for hospital-supplied isotopes. Vehicles are specially modified and licensed.

• Air Critical for time-sensitive radiopharmaceuticals. Regulatory approval and aircraft shielding certification are mandatory.

• Rail & Maritime Used for bulk fuel and waste shipments across regions or international borders. Japan, Russia, and France lead in this segment due to well-established nuclear logistics corridors.

 

By End User

• Nuclear Medicine Facilities & Hospitals These include both large academic hospitals and independent cancer centers. They rely on Just-In-Time (JIT) isotope delivery to perform diagnostic scans without waste.

• Nuclear Power Plants Fuel in, waste out. Utilities need integrated logistics support that includes container tracking, accident mitigation plans, and compliance across jurisdictions.

• Research Laboratories & Defense Agencies Transport of experimental isotopes, neutron sources, or defense-grade materials. Highly confidential and often executed under government or military escort.

 

By Region

• North America Strong presence of nuclear medicine hubs and waste storage logistics, especially in the U.S. and Canada.

• Europe High-volume cross-border transport driven by Euratom agreements and shared reprocessing facilities (e.g., France’s La Hague).

• Asia Pacific Fastest-growing, with India, China, and South Korea expanding both reactor fleets and nuclear medicine facilities.

• Latin America, Middle East & Africa (LAMEA ) Still emerging but showing steady uptake in medical isotopes and reactor projects.

 

3. Market Trends and Innovation Landscape

The radioactive materials logistics market is evolving fast — and not just because of tech upgrades. The shift is deeper. It’s being driven by rising urgency in healthcare, changing reactor designs, and a growing global focus on regulatory transparency. Logistics providers now have to be part transporter, part compliance partner, and part data integrator.

Digital Chain-of-Custody is Becoming the Norm

One major shift is the move toward digital tracking systems for radioactive shipments. Regulators and end users now expect real-time updates, from dispatch to delivery. Advanced RFID tags, geofencing , and tamper-detection sensors are increasingly built into shielding containers. Some vendors are offering blockchain -based chain-of-custody to ensure immutable records — especially important for spent fuel and defense-sensitive isotopes.

One logistics manager in a French nuclear hospital noted: “If I can’t show timestamped compliance records instantly, I’m already behind.”

 

Specialized Container Tech is Getting Smarter

Next-generation Type A and Type B( U) containers are being designed with better heat resistance, shielding flexibility, and shock-absorbing layers. These containers often include built-in temperature logs, GPS modules, and even neutron flux sensors. The demand for modular container solutions is rising — especially among isotope producers who ship multiple isotopes with different half-lives and decay heat characteristics in the same load.

 

AI Is Being Used for Routing and Risk Mitigation

Artificial intelligence is now being applied to optimize routes based on:

• Regulatory zoning (urban vs. restricted zones)

• Traffic and weather conditions

• Real-time threat analysis (e.g., protest activity or geopolitical tension)

AI can dynamically re-route shipments in case of delays while ensuring compliance with shipment duration limits set by isotope half-lives.

In the U.S., some air cargo routes for radiopharmaceuticals are now AI-managed to maintain delivery within a 4–6 hour time window.

 

Healthcare-Driven Logistics is Redefining Speed

Nuclear medicine is pushing the logistics industry hard. PET isotopes like F-18 decay within hours, so any delay ruins the payload. This is spurring investments in dedicated last-mile delivery fleets — including motorcycle couriers, drone prototypes, and even hospital-based isotope generation units paired with micro-distribution networks.

 

Private Sector Nuclear Fuel Logistics Is Expanding

With the rise of small modular reactors (SMRs) and newer fuel cycles (e.g., thorium, TRISO), private companies are entering what was once a strictly government domain. These players are demanding more transparent, cost-optimized logistics — creating demand for commercial providers who understand the nuances of spent fuel shielding, thermal margins, and cross-border clearance.

 

International Harmonization Is in Focus

The IAEA is working with regional regulators to align Class 7 Dangerous Goods transport rules , and simplify approvals for multi-country shipments. Europe is ahead on this, with integrated customs-exempt routes for Euratom -certified materials. Asia Pacific is next — especially with Japan and India leading on nuclear cooperation treaties.

To sum it up, radioactive logistics isn’t standing still. The most successful players aren’t just buying safer trucks or faster jets — they’re redesigning the entire ecosystem: containers, software, routing, and regulatory engagement.

 

4. Competitive Intelligence and Benchmarking

The radioactive materials logistics market isn’t crowded — but it’s complex. A few highly specialized firms dominate globally, while regional players compete on licensing agility and localized knowledge. The ability to navigate regulation is more valuable here than pricing power. Let’s take a closer look at who’s shaping this space.

DHL Global Forwarding

DHL runs one of the largest controlled logistics networks for Class 7 dangerous goods , including radioactive materials. They offer integrated cold chain solutions for radiopharmaceuticals , with rapid customs clearance, temperature-controlled packaging, and 24/7 tracking. Their partnerships with nuclear medicine suppliers make them a go-to for high-frequency, time-critical shipments.

Their strength lies in global scale and pharma-grade cold chain operations — especially across Europe, the U.S., and parts of Asia.

 

DSV

DSV is gaining traction with flexible multimodal solutions for radioactive cargo. They’re well-positioned in Europe, especially for reactor fuel and industrial isotopes. The company emphasizes cross-border regulatory handling and has built expertise in navigating the European ADR framework.

They often serve niche clients: medical isotope producers, research labs, and regional energy agencies.

 

Global Nuclear Fuel Services (GNF )

A joint venture involving GE Hitachi Nuclear Energy , GNF focuses specifically on nuclear fuel transport — fresh and spent. Their focus is tightly aligned with utilities and government agencies. They manage everything from fuel assemblies to dry cask systems, with integrated shielding and shock resistance systems.

They don’t compete in healthcare — but they dominate the power sector segment.

 

ECS Logistics

A U.S.-based company that’s carved out a strong niche in PET isotope logistics . ECS specializes in same-day, real-time-tracked deliveries of F-18 and other short-lived isotopes to hospitals and diagnostic centers. Their fleet is tailored for radioactive shielding, temperature stability, and strict delivery windows.

They’ve become a backbone provider for radiopharmacies and smaller cancer clinics across North America.

 

Heathgate Resources / Logistics Subdivisions

Operating out of Australia, Heathgate handles radioactive ores, including uranium mining outputs , and offers secure logistics through remote geographies. While not a global logistics provider, their specialization in long-haul terrestrial shipments under high-security protocols sets them apart.

 

Mitsui- Soko Group

In Japan, Mitsui- Soko manages radioactive cargo logistics for research isotopes, fuel shipments, and medical materials . Their strong government ties and proximity to nuclear reactor infrastructure make them essential to Japan’s nuclear logistics strategy. They often collaborate with international partners on long-range fuel shipment and storage projects.

 

Competitive Dynamics at a Glance

• DHL and DSV dominate healthcare and cross-border isotope logistics with digital traceability and cold-chain integration.

• GNF and Mitsui- Soko lead the fuel cycle segment, especially in state-backed or utility-driven projects.

• Regional players like ECS Logistics thrive by owning the last mile in isotope delivery — a space where timing beats scale.

• Technical certification and regulatory alignment are non-negotiables. Vendors without Class 7 certification and radiation safety officers simply don’t compete here.

 

5. Regional Landscape and Adoption Outlook

The radioactive materials logistics market looks very different depending on where you're standing. While regulation is universally strict, investment, infrastructure, and local acceptance vary drastically across regions. Some countries are doubling down on nuclear innovation. Others are just building basic isotope delivery networks. Here's how it breaks down.

North America

This is still the most mature logistics environment — but not without friction. The U.S. has a sprawling network of nuclear medicine centers, over 90 operational reactors, and extensive research activity. That means high-volume movement of:

• Radiopharmaceuticals , often via air and road

• Spent fuel heading to interim storage

• Experimental isotopes from labs like Oak Ridge and Brookhaven

Regulatory control is tight, especially under NRC and DOT Class 7 protocols , but logistics innovation is also robust. Last-mile PET isotope delivery is evolving into a hyper-specialized niche, particularly in states like California and Texas. In Canada, isotope production (e.g., molybdenum-99, cobalt-60) drives interprovincial logistics demand — often under license from Canadian Nuclear Safety Commission (CNSC).

The U.S. also sees significant logistics activity tied to defense-grade materials and fuel transport for naval reactors — sectors that rarely get public attention but account for complex high-security routing.

 

Europe

Europe excels in harmonized transport rules. Thanks to Euratom , ADR compliance, and established routes between production and reprocessing facilities (e.g., France to the UK, Germany to Belgium), cross-border radioactive materials transport is routine and streamlined.

France, for instance, runs one of the most advanced radioactive logistics networks in the world. Its La Hague facility is a global hub for spent fuel reprocessing — and shipments are handled by specialized sea and rail carriers. Germany, meanwhile, is phasing out nuclear energy but still relies on precision logistics for decommissioning, isotope supply, and export.

In healthcare, radiopharmaceutical demand is rising due to cancer screening programs and aging populations. Vendors in Italy and Scandinavia are now investing in just-in-time delivery networks for hospital diagnostics.

 

Asia Pacific

This is where most of the future market growth lies — but also where logistical gaps are widest. China and India are adding reactors and medical isotope centers rapidly. South Korea and Japan already have robust nuclear programs but are shifting toward next-gen solutions like SMRs and advanced nuclear fuel cycles.

Key themes in this region:

• China is investing heavily in regional isotope distribution hubs, aiming to serve Tier 2 and Tier 3 cities with same-day delivery options.

• India faces infrastructure hurdles. Road transport for Class 7 goods is permitted but logistically constrained by state-level permitting, aging vehicles, and limited cold-chain networks.

• Japan remains highly compliant and innovation-forward, particularly in radiopharmaceutical logistics and nuclear R&D shipments.

South Korea’s nuclear medicine sector is growing fast, and logistics is being built alongside, often with automation and AI-led compliance systems.

 

Latin America, Middle East & Africa (LAMEA)

Still nascent — but not inactive.

• Brazil is leading the Latin American charge, both in isotope production and reactor expansion. But logistics coverage is still sparse outside major metro areas.

• Mexico has decent capability in urban zones but lags in long-range shipment protocols.

• Saudi Arabia and the UAE are modernizing their nuclear strategies, and logistics investments are being folded into broader energy and defense infrastructure programs.

• Africa , overall, remains the most underserved region. NGOs and global health initiatives are stepping in to enable radiopharmaceutical delivery to cancer hospitals in Kenya, South Africa, and Ghana — but it's early days.

 

6. End-User Dynamics and Use Case

Unlike traditional logistics markets, radioactive materials logistics is shaped almost entirely by the user’s risk tolerance, time sensitivity, and regulatory scrutiny. From hospitals to energy utilities to government labs, each user group has different demands — and logistics providers have to adapt accordingly.

Nuclear Medicine & Diagnostic Imaging Centers

This is arguably the most logistics-dependent end-user group. Hospitals performing PET, SPECT, and gamma scans need isotopes delivered daily , sometimes multiple times a day , depending on their caseload. Since isotopes like Fluorine-18 have half-lives of only a few hours, any delay renders the shipment useless.

Most hospitals work with specialized third-party couriers who offer:

• Shielded and temperature-controlled containers

• Real-time tracking with geofencing

• Pre-cleared air cargo slots or licensed road vehicles

Large oncology centers in Europe and North America are pushing for drone-based delivery pilots to improve last-mile timing.

 

Nuclear Power Utilities

Utilities are more focused on long-haul and bulk shipments — typically of fresh fuel , used fuel rods , or intermediate-level waste . These customers demand:

• Multi-modal transport (road, rail, sea)

• ISO-certified containers with robust shielding

• Detailed accident mitigation planning

Turnaround time is less of a constraint — but compliance is everything. Most of these operations are coordinated months in advance and often involve government or IAEA oversight .

 

Research Labs & Universities

Research centers handle a wide variety of isotopes, including short-lived and rare materials for experimental physics, radiochemistry, or pharmaceutical development. Their logistics needs are diverse and often unpredictable. They rely on providers who can secure:

• Rapid cross-border clearances

• Handling of exotic or small-batch materials

• Non-standard container formats

Universities in the U.S., Japan, and France are frequent recipients of small-volume, high-compliance radioactive shipments.

 

Defense & Security Agencies

Though highly confidential, military and national defense organizations routinely ship radioactive sources used in naval propulsion, weapons research, and detection systems. These shipments are tightly controlled under special clearance. Logistics partners must hold:

• Government security clearance

• Experience with classified payload routing

• Coordination with law enforcement during transit

Only a few logistics firms globally meet these requirements.

 

Use Case Highlight

A mid-sized nuclear medicine center in Germany had a recurring issue with isotope losses due to delayed flights and urban traffic. The facility was using a global courier that couldn’t guarantee 6 a.m. arrival for Fluorine-18 needed for PET scans. Over several months, canceled scans began affecting revenue and patient flow.

In 2023, the center switched to a regional radiopharmacy supplier who built a dedicated isotope delivery loop using pre-cleared road routes, real-time GPS tracking, and automated ETA updates. The result? Delivery failures dropped by 95%, scan volumes increased, and the provider built a niche logistics business that now serves four nearby hospitals.

 

7. Recent Developments + Opportunities & Restraints

Recent Developments (Past 2 Years)

• GE Healthcare and BWXT Medical formed a radiopharmaceutical logistics partnership (2024) aimed at optimizing isotope delivery across North America. The agreement includes cold-chain asset tracking and shared distribution hubs in major metro regions.

• IAEA launched its Digital Traceability Framework for Transboundary Radioactive Shipments (2023), aimed at harmonizing reporting across 28 member states. Early adopters include Germany, South Korea, and Canada.

• DHL expanded its Class 7-certified logistics fleet in Asia-Pacific , establishing new radioactive material handling facilities in Singapore and Bengaluru, India. The expansion targets both nuclear medicine and reactor materials.

• NorthStar Medical Radioisotopes received FDA approval (2023) for a domestic Mo-99 production line, reducing dependency on international isotope imports — a shift expected to localize logistics demand in the U.S.

• Australia’s ANSTO piloted drone delivery of radiopharmaceuticals (2023), successfully delivering Iodine-123 over a 22km route under license from ARPANSA. This has implications for future same-day delivery networks in rural zones.

 

Opportunities

• Decentralized Radiopharmaceutical Supply Chains With new isotope production units being installed at hospital level, especially in Europe and North America, there’s growing need for short-route, high-frequency logistics models — a new frontier for specialized 3PLs.

• Asia-Pacific Infrastructure Expansion India, China, and South Korea are investing heavily in nuclear facilities and isotope production, opening white space for logistics players with Class 7 certifications and multimodal capabilities .

• Digital Compliance & Route Management AI-powered dashboards for monitoring, auditing, and incident tracking are in high demand. Logistics vendors offering integrated compliance-as-a-service platforms can win long-term contracts.

 

Restraints

• High Cost of Certification & Operations From radiation shielding to regulatory training, setting up compliant logistics networks is extremely capital-intensive. Many general logistics firms can’t enter this niche.

• Workforce Limitations There’s a global shortage of certified radiation safety personnel capable of handling radioactive cargo — particularly in emerging markets.

 

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 3.2 Billion
Revenue Forecast in 2030	USD 4.8 Billion
Overall Growth Rate	CAGR of 5.9% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Material Type, By Mode of Transport, By End User, By Geography
By Material Type	Radiopharmaceuticals, Nuclear Fuel, Industrial Isotopes, Nuclear Waste
By Mode of Transport	Road, Air, Rail, Maritime
By End User	Nuclear Medicine Facilities, Power Plants, Research Labs, Defense Agencies
By Region	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, Germany, France, India, China, Japan, Brazil, UAE, Australia
Market Drivers	- Rising demand for radiopharmaceutical logistics - Growth in nuclear power and fuel cycle logistics - Advances in AI-led compliance and routing systems
Customization Option	Available upon request